Hydrogen Gas Inhalation Protects Against Lung Disease in Rats
- Authors
- Chenting Zhang, Yue Xing, Xuefen Wu, Qian Jiang, Xiaoyun Luo, Wei He, Shiyun Liu, Wenju Lu, Jian Wang
- Journal
- Respiratory Research
- Year
- 2024
- DOI
- 10.1186/s12931-024-02906-y
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Pulmonary Veno-Occlusive Disease
- Body System
- Respiratory
TL;DR
Breathing in hydrogen gas can help prevent and treat a severe lung disease called pulmonary veno-occlusive disease (PVOD) in rats.
Key Finding
Inhaled hydrogen gas prevented and reversed pulmonary veno-occlusive disease in rats, improving heart function and reducing lung damage through antioxidant and anti-inflammatory mechanisms.
Summary
Researchers tested whether inhaled hydrogen gas could prevent or treat a serious lung disease called pulmonary veno-occlusive disease (PVOD) in rats. They induced PVOD using a drug called mitomycin C, then gave some rats hydrogen gas to breathe either at the same time as the drug or two weeks after. Hydrogen gas treatment improved heart function, reduced lung damage, and lowered markers of oxidative stress (cellular damage from harmful molecules) and inflammation in the rats' lungs and blood.
Practical Takeaway
This rat study suggests hydrogen gas inhalation may have potential as a treatment for a severe form of pulmonary hypertension, but this is very early-stage research. The findings cannot yet be applied to humans, and much more research would be needed before hydrogen inhalation could be considered a viable therapy for this condition in people.
Abstract (excerpt)
Background: As a subtype of pulmonary hypertension (PH), pulmonary veno-occlusive disease (PVOD) is devastating and life-threatening disease without effective therapy. Hydrogen has been reported to exhibits antioxidant and anti-inflammatory effects in a rat model induced by monocrotaline of PH…